MRI Following Stereotactic Radiosurgery (SRS) for Brain Metastases

Running, not enrolling · Not applicable

Conditions studied: Brain Metastases

In brief

The purpose of this study is to test whether an additional magnetic resonance image (MRI) sequence can improve the ability to distinguish radiation damage from tumor recurrence in participants with brain metastasis who have previously been treated with stereotactic radiosurgery (SRS).

Key facts

Study ID

NCT04246879

Run by

Duke University

People needed

25

Starts

2021-07-19

Expected to finish

2027-03-24

Last updated by the study team

2026-05-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult patients, age ≥18
• Metastatic malignancy with at least 1 brain metastasis previously treated with SRS
• Patients may have also received whole brain radiation therapy (WBRT) for management of brain metastatic disease but this is not required for study participation
• Patients must have been diagnosed with a metastatic solid tumor of any histological type except small cell lung cancer (SCLC), or lymphoma.
• Radiographic progression on post-SRS imaging at previously treated SRS site(s)
• Must be a candidate for brain surgery as determined by treating neurosurgeon and/or anesthesia team
• Patients must sign study-specific informed consent prior to study entry

You may not qualify if…

• Poor surgical candidate as determined by treating neurosurgeon and/or anesthesia team
• Unable to undergo contrasted MRI (e.g. incompatible medical device, inadequate renal function per standard institutional clinical protocol, contrast allergy)
• Small cell lung cancer (SCLC) or lymphoma histology

Where it is running

• Duke University Health System — Durham, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.